Obsidian Therapeutics Q3 EPS $(1.23) Up From $(14.77) YoY

Benzinga · 4d ago
Obsidian Therapeutics (NASDAQ:OBX) reported quarterly losses of $(1.23) per share. This is a 91.67 percent increase over losses of $(14.77) per share from the same period last year.